Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Allygen Biologics Closes Over RMB 300 Million Series A Led by Sherpa Healthcare Partners – Funding to Propel STAR‑BiADC Candidate ALG01 into Phase 1
CompanyDeals

Allygen Biologics Closes Over RMB 300 Million Series A Led by Sherpa Healthcare Partners – Funding to Propel STAR‑BiADC Candidate ALG01 into Phase 1

Allygen Biologics announced the completion of over RMB 300 million (≈ US$42 million) in Series A financing, led by Sherpa Healthcare Partners, with participation from the Beijing Medical and Health…

BMS's RYZ101 Meets Primary Endpoint in Phase 3 ACTION‑1 Trial – Alpha‑Emitting Radiopharmaceutical Shows Significant PFS Benefit in Post‑Lu177 GEP‑NETs

BMS’s RYZ101 Meets Primary Endpoint in Phase 3 ACTION‑1 Trial – Alpha‑Emitting Radiopharmaceutical Shows Significant PFS Benefit in Post‑Lu177 GEP‑NETs

Huadong Medicine Subsidiary Doer Bio's DR30206 Cleared for Clinical Trials by NMPA – Triple‑Targeting PD‑L1/VEGF/TGF‑β Fusion Protein Advances Against Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Huadong Medicine Subsidiary Doer Bio’s DR30206 Cleared for Clinical Trials by NMPA – Triple‑Targeting PD‑L1/VEGF/TGF‑β Fusion Protein Advances Against Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Yantai Dongcheng Pharma’s 177Lu-LNC1003 Cleared for US FDA Phase I Study

CompanyDrug

ABM Therapeutics’ ABM-168 Begins Phase I Dosing in the US for Advanced Solid Tumors

CompanyDrug

CARsgen Therapeutics’ AB011 and Tecentriq Combo Gets NMPA Approval for Gastric Cancer Treatment

CompanyDrug

BDgene Technology’s BD111 Receives Tacit Approval for HSV-1 Keratitis Trial

CompanyDrug

TYK Medicines’ TY-9591 Gains CDE Green Light for Pivotal Phase II Study in NSCLC with Brain Metastases

CompanyDrug

CMS Receives NMPA Approval for Clinical Study of Tetravalent BsAb for nAMD

CompanyDrug

Sirnaomics’ RV-1730 Receives FDA Clearance for Phase I COVID-19 Vaccine Booster Trial

CompanyDrug

SynerK Achieves Milestone with First Patient Dosing in Phase I siRNA Clinical Trial

Show More